---
title: 'å‰äººç•™çµ¦ç¾ä»£äººé™è¡€è„‚ã€é™è¡€ç³–ã€æŠ—ç–²å‹ç­‰ç­‰å¤šåŠŸæ•ˆçš„è–å“ï¼ç´…éº´'
description: 'ç´…éº´ï¼ˆRed Yeast Riceï¼‰ï¼Œåˆåèµ¤éº´ã€ä¸¹éº´ã€ç´…éº´é»´èŒï¼ˆMonascus purpureusï¼‰ï¼›Monï¼Œæ„æ€æ˜¯ã€Œå–®ä¸€ã€ï¼Œ ascusï¼Œ æ„æ€æ˜¯ã€Œå›Šã€ï¼Œpurpureus ï¼Œæ„æ€æ˜¯ã€Œæ·±ç´…ã€ï¼Œæ„æ€å°±æ˜¯ã€Œå–®ä¸€æ·±ç´…è‰²çš„å­å›Šã€ã€‚åœ¨æ—¥æœ¬ç¨±ç‚º beni koji æˆ– anka kojiï¼Œæ­ç¾å‰‡ä»¥ red yeast'
pubDate: 2024-12-08T12:08:54+08:00
---

_1.6K_

å…§å®¹ç›®éŒ„

Toggle

## **ç´…éº´æ˜¯ä»€éº½ï¼Ÿ**

**ç´…éº´** ï¼ˆRed Yeast Riceï¼‰ï¼Œåˆåèµ¤éº´ã€ä¸¹éº´ã€**ç´…éº´é»´èŒ** ï¼ˆMonascus purpureusï¼‰ï¼›Monï¼Œæ„æ€æ˜¯ã€Œå–®ä¸€ã€ï¼Œ ascusï¼Œ æ„æ€æ˜¯ã€Œå›Šã€ï¼Œpurpureus ï¼Œæ„æ€æ˜¯ã€Œæ·±ç´…ã€ï¼Œæ„æ€å°±æ˜¯ã€Œå–®ä¸€æ·±ç´…è‰²çš„å­å›Šã€ã€‚åœ¨æ—¥æœ¬ç¨±ç‚º beni koji æˆ– anka kojiï¼Œæ­ç¾å‰‡ä»¥ red yeast rice ç¨±ä¹‹ã€‚

ç´…éº´èŒå»£æ³›å­˜åœ¨æ–¼ç©€é¡ã€æ¾±ç²‰ã€æ–°é®®ç‰§è‰ã€æ³¥åœŸå’Œæ¾æ¨¹æ ¹çµ„ç¹”ä¸­ï¼Œåœ¨ä¸­åœ‹ä½¿ç”¨è¶…éåƒå¹´ä»¥ä¸Šã€‚

è¥¿å…ƒ 965 å¹´ï¼ŒåŒ—å®‹é™¶ç©€åœ¨ã€Šæ¸…ç•°éŒ„ã€‹ä¸Šè¨˜è¼‰ï¼šã€Œå­Ÿèœ€å°šé£Ÿï¼ˆäº”ä»£ååœ‹çš„å¾Œèœ€ï¼‰ï¼ŒæŒã€Šé£Ÿå…¸ã€‹ä¸€ç™¾å·ï¼Œæœ‰è³œç·‹ç¾Šã€‚å…¶æ³•ä»¥ç´…æ›²ç…®è‚‰ï¼Œç·Šå·çŸ³é®ï¼Œæ·±å…¥é…’éª¨æ·¹é€ï¼Œåˆ‡å¦‚ç´™è–„ä¹ƒé€²ï¼Œæ³¨äº‘ã€é…’éª¨ç³Ÿã€ä¹Ÿã€‚ã€é€™è£¡çš„ã€Œç´…æ›²ç…®è‚‰ã€æŒ‡çš„å°±æ˜¯ç”¨ç´…éº´çƒ¹èª¿è‚‰é¡ã€‚

è€Œå°ç£ä½¿ç”¨çš„ç´…éº´èŒç´€éŒ„ï¼Œæ“šå‚³å§‹æ–¼é„­æˆåŠŸè‡ªç¦å»ºå¼•é€²è£½é…’åŒ ä¾†å°ã€‚åœ¨å°çš„æ—¥æœ¬å­¸è€…**é½Šè—¤è³¢é“** ï¼ˆã•ã„ã¨ã† ã‘ã‚“ã©ã†ï¼‰æ–¼è¥¿å…ƒ 1908 å¹´ç”±ç´…éº´ä¸­åˆ†é›¢å‡ºç´…éº´èŒï¼Œè¥¿å…ƒ 1930 å¹´**ä¸­æ¾¤äº®æ²»** ï¼ˆãªã‹ã–ã‚ã‚Šã‚‡ã†ã˜ï¼‰åŠä½è—¤å–œå‰å¾å°ç£æ°‘é–“ä½¿ç”¨çš„ç´…éº´ä¸­åˆ†é›¢å‡ºå„ªè‰¯çš„èŒç¨®ï¼Œå‘½åç‚º _Monascus anka_ ï¼Œå…¶åç¨± ã€Œankaã€ä¹ƒç´…éº´çš„é–©å—èªç™¼éŸ³ã€‚

ç´…éº´è‡ªå¤ä»¥ä¾†ä»¥ä¸‹å››ç¨®ç”¨æ³•æœ€ç‚ºå¸¸è¦‹ï¼š

### **ä¸€ã€å¤©ç„¶è‰²ç´ **

å¤ä»£æœªç™¼æ˜é†¬æ²¹å°ˆç”¨é†¬è‰²ï¼ˆç„¦ç³–ï¼‰ä¹‹å‰ï¼Œç´…éº´æ˜¯ç´…ç‡’è‚‰å’Œå…¶ä»–ç´…è‰²é£Ÿå“çš„ä¸»è¦é£Ÿç”¨è‰²ç´ ï¼Œå› ç‚ºåœ¨æ‰€æœ‰å·²çŸ¥çš„å¤©ç„¶è‰²ç´ ä¸­ï¼Œç´…éº´è‰²ç´ ç›¸å°æ¯”è¼ƒç©©å®šï¼ˆç†±ã€é…¸ã€é«˜é¹½ã€é«˜ç³–ä»¥åŠé¹½åŸºç‰©ï¼‰ï¼Œé…¸é¹¼å€¼çš„è€å—åº¦ç¯„åœå¤§ï¼ˆpH 3 ~ 12ï¼‰ï¼Œä¸å®¹æ˜“è¤ªè‰²ï¼Œå› æ­¤å¸¸ç”¨æ–¼å¹«é£Ÿç‰©æŸ“è‰²ï¼Œäº¦å¯ä¿æŒé£Ÿå“çš„é®®åº¦ã€‚

å‚³çµ±ç¯€æ—¥ç•¶ä¸­å¸¸æœƒå‡ºç¾çš„ã€Œç´…è›‹ã€ã€ã€Œç´…é¾œç²¿ã€åŠã€Œç´…æ¹¯åœ“ã€ç­‰å‚³çµ±é£Ÿç‰©ï¼Œä¾¿æ˜¯é€éç´…éº´è‰²ç´ æŸ“ä¸Šå–œæ…¶çš„é¡è‰²ï¼Œè—‰ä»¥æ»¿è¶³è¦–è¦ºè§€æ„Ÿä¸¦åˆºæ¿€é£Ÿæ…¾ã€‚

ç´…éº´èŒæ‰€ç”¢ç”Ÿçš„è‰²ç´ æœ‰ç´…è‰²çš„**ç´…éº´ç´…èƒºç´ ** ï¼ˆMonascorubramineï¼‰èˆ‡**ç´…æ–‘èƒºç´ ** ï¼ˆRubropunctamineï¼‰ã€æ©™è‰²çš„**ç´…éº´ç´…ç´ ** ï¼ˆMonascorubrinï¼‰èˆ‡**ç´…æ–‘ç´ ** ï¼ˆRubropunctatinï¼‰ï¼Œä»¥åŠé»ƒè‰²çš„**ç´…éº´é»ƒç´ ** ï¼ˆAnkaflavinï¼‰èˆ‡**ç´…éº´ç´ ** ï¼ˆMonascinï¼‰ã€‚

### **äºŒã€æŠ—èŒä¿é®®**

ç´…éº´æŠ‘èŒé˜²è…çš„åŠŸæ•ˆæ—©æ–¼æ˜æœæœ«å¹´å®‹æ‡‰æ˜Ÿå…¶æ‰€è‘—ã€Šå¤©å·¥é–‹ç‰©ã€‹æœ‰ä»‹ç´¹ç´…éº´çš„é˜²è…æ•ˆæœï¼šã€Œå‡¡ä¸¹éº´ä¸€ç¨®ï¼Œæ³•å‡ºè¿‘ä»£ã€‚å…¶ç¾©è‡­è…ç¥å¥‡ï¼Œå…¶æ³•æ°£ç²¾è®ŠåŒ–ã€‚ä¸–é–“é­šè‚‰æœ€è…æœ½ç‰©ï¼Œè€Œæ­¤ç‰©è–„æ–½å¡—æŠ¹ï¼Œèƒ½å›ºå…¶è³ªæ–¼ç‚æš‘ä¹‹ä¸­ï¼Œç¶“æ­·æ—¬æ—¥ï¼Œè›†è …ä¸æ•¢è¿‘ï¼Œè‰²å‘³ä¸é›¢åˆï¼Œè“‹å¥‡è—¥ä¹Ÿã€ã€‚

ç´…éº´çš„ç´…éº´å…§é…¯ã€ç´…éº´ç´…ç´ ï¼ˆMonascorubrinï¼‰èˆ‡ç´…æ–‘ç´ ï¼ˆRubropunctatinï¼‰å¯æ®ºæ­»å¤§è…¸æ¡¿èŒï¼ˆ _E_._coli_ ï¼‰ã€ç—¢ç–¾æ¡¿èŒï¼ˆ _Bacterium dysenteriae_ ï¼‰ã€å‡å–®èƒèŒå±¬ï¼ˆ _Pseudomonas_ ï¼‰åŠæ¯è‰èŠ½å­¢æ¡¿èŒï¼ˆ _Bacillus subtilis_ ï¼‰ã€‚

è¥¿å…ƒ 1979 å¹´æ±å³å¤§å­¸**é»ƒé¡¯å®—** ï¼ˆHin-Chung Wanï¼‰æ•™æˆå¾ç´…éº´ä¸­åˆ†é›¢å‡ºä¸€ç¨®æŠ—èŒåŒ–åˆç‰© Monascidin Aï¼Œå¯æŠ‘åˆ¶æ¡¿èŒå±¬ï¼ˆ _Bacillus_ ï¼‰ã€å‡å–®èƒèŒå±¬ï¼ˆ _Pseudomonas_ ï¼‰åŠéˆçƒèŒå±¬ï¼ˆ _Streptococcus_ ï¼‰ç”Ÿé•·ã€‚

è¥¿å…ƒ 1995 å¹´å­¸è€… Blanc ç­‰äººè­‰æ˜ç´”åŒ–çš„ Monascidin Aï¼Œå…¶çµæ§‹èˆ‡**æª¸æª¬é»ƒé’é»´** ï¼ˆ _Penicillium citrinum_ ï¼‰åŸ¹é¤Šæ¶²ä¸­è¢«åˆ†é›¢å‡ºä¾†çš„æ©˜é»´ç´ ï¼ˆCitrininï¼‰åˆ†å­ç›¸åŒï¼ŒåŒæ™‚ä¹Ÿå°è­‰äº†å¤äººä½¿ç”¨ç´…éº´é˜²æ­¢é£Ÿç‰©è…æ•—çš„æ™ºæ…§ã€‚

### ä¸‰ã€**é‡€é…’**

ç´…éº¯é…’è‡ªå¤ä»¥ä¾†ç‚ºç™’ç—…å¥èº«çš„åé…’ï¼Œæ˜¯ç”±ç´…éº´èŒå’Œé…µæ¯èŒä¸€èµ·åˆä½œçš„ã€‚ ç´…éº´èŒèƒ½å¤ å°‡ç³¯ç±³ä¸­çš„æ¾±ç²‰åˆ†è§£ç‚ºå–®é†£ï¼Œè€Œé…µæ¯èŒéš¨å¾Œç¹¼çºŒé€²ä¸€æ­¥è½‰åŒ–ç‚ºé…’ç²¾ã€‚

ç¦å»ºåœ°å€åœ¨ä¸­åœ‹æ˜¯å±ˆæŒ‡å¯æ•¸çš„ç³¯ç±³ç”¢åœ°ï¼ŒæŒ‰ç¦å»ºçš„æ–¹è¨€ï¼Œã€Œç³¯ã€èˆ‡ã€Œè€ã€çš„æ¯éŸ³ç›¸åŒï¼Œç™¼éŸ³è¿‘ä¼¼ï¼Œå› æ­¤å°‡ç³¯ç±³é…’è®€ä½œå®¹æ˜“ç™¼éŸ³çš„è€ç±³é…’ï¼Œä¸¦ä¸€ç›´æ²¿è¥²ä¸‹ä¾†ï¼Œå†åŠ ä¹‹è‰²èª¿é®®ç´…çš„æ¿ƒåšå‘³é“ï¼Œå› è€Œç•¥ä¹‹ç¨±ä½œè€é…’ã€‚

åŒ—å®‹é†«å­¸å®¶èŠç¶½åœ¨å…¶ä½œã€Šé›è‚‹ç·¨ã€‹ä¸‹å·ä¸­å°±å¯«åˆ°ã€Œæ±Ÿå—ã€é–©ä¸­å…¬ç§é†é‡€ï¼Œçš†ç´…éº´é…’ã€ã€‚å—å®‹æœ«å¹´ã€Šäº‹æ—å»£è¨˜ã€‹ä¸­å°±æåˆ°äº†ã€Œé€ ç´…éº´æ³•ã€å’Œç´…éº´é…’çš„ã€Œæ±é™½é†æ³•ã€ã€‚

æµ™æ±Ÿå°å·å¤©å°ç¸£æ˜¯æµ™æ±Ÿç´…é…’çš„ä¸»è¦ç”¢åœ°ï¼Œå…ƒæœã€Šå±…å®¶å¿…ç”¨äº‹é¡å…¨é›†ã€‹èˆ‡å…ƒæœ«æ˜åˆçš„ã€Šæ˜“ç‰™éºæ„ã€‹ä¸­å‰‡åˆ†åˆ¥è¨˜éŒ„äº†ã€Œå¤©å°ç´…é…’ã€å’Œã€Œå»ºæ˜Œç´…é…’ã€çš„è£½ä½œæ–¹æ³•ã€‚

è€Œå°ç£æœ€æ—©ç´…éº´é…’æ˜¯åœ¨æ¸…æ²»æœ«æœŸçš„å®œè˜­ç¸£ï¼Œè¥¿å…ƒ 1909 å¹´å‡ºèº«è£½é…’ä¸–å®¶çš„æ—é’é›²é‹ç”¨ä»–å…ˆç¥–åœ¨å®‰æºªå­¸ç¿’å¾—ä¾†çš„ç´…éº´ç±³é‡€é…’æ³•ï¼Œæˆç«‹ã€Œå®œè˜­é…’å» ã€ï¼Œé–‹å§‹é‡ç”¢ã€Œå®‰æºªè€ç´…é…’ã€ã€‚

è¥¿å…ƒ 1946 å¹´ï¼Œå®œè˜­é…’å» å°‡å…¶æ”¹åç‚ºã€Œç´…éœ²é…’ã€ï¼Œè¥¿å…ƒ 2006 å¹´ç¸£æ°‘å…¬æŠ•ï¼Œæ“„ç² 98% çš„ç¸£æ°‘æ”¯æŒï¼Œæ•…æ˜è¨‚ç´…éœ²é…’ç‚ºã€Œå®œè˜­ç¸£é…’ã€ï¼Œé¦–é–‹å…¨å°å…ˆä¾‹ã€‚

### **å››ã€å…¥è—¥**

å…ƒæœå³ç‘æ‰€è‘—çš„ã€Šæ—¥ç”¨æœ¬è‰ã€‹æ‰€æ•˜ä¹‹ã€Œç´…æ›²é‡€é…’ï¼Œç ´è¡€è¡Œè—¥å‹¢ã€ï¼›å…ƒæœå¤ªé†«å¿½æ€æ…§ã€Šé£²è†³æ­£è¦ã€‹æ›°ï¼šã€Œç´…æ›²ï¼›å‘³ç”˜ã€æ€§å¹³ã€ç„¡  
æ¯’ï¼Œå¥è„¾ã€ç›Šæ°£ã€æº«ä¸­ã€ã€‚

æ ¹æ“šæ˜æœææ™‚ççš„ã€Šæœ¬è‰ç¶±ç›®ã€‹è¨˜è¼‰ï¼šã€Œéº´ä¸»æ²»æ¶ˆé£Ÿæ´»è¡€ï¼Œå¥è„¾ç‡¥èƒƒã€‚æ²»èµ¤ç™½ç—¢ï¼Œä¸‹æ°´æ®¼ã€‚é‡€é…’ç ´è¡€è¡Œè—¥å‹¢ï¼Œæ®ºå±±åµéšœæ°£ï¼Œæ²»æ‰“æ’²å‚·æï¼Œæ²»å¥³äººè¡€æ°£ç—›åŠç”¢å¾Œæƒ¡è¡€ä¸ç›¡ã€ã€‚

éš¨å¾Œï¼Œæ˜æœæœ«å¹´å®‹æ‡‰æ˜Ÿå…¶æ‰€è‘—ã€Šå¤©å·¥é–‹ç‰©ã€‹åŠæœ±ä¸¹æºªã€Šæœ¬è‰è¡ç¾©è£œéºã€‹è¨˜è¼‰ã€Œç´…éº´ï¼Œæ´»è¡€æ¶ˆé£Ÿï¼Œå¥è„¾ç‡¥èƒƒï¼Œæ²»èµ¤ç™½ç—¢ï¼Œä¸‹æ°´ç©€ï¼Œé™³ä¹…è€…è‰¯ã€ã€‚ç¹†å¸Œé›è‘—ã€Šç¥è¾²æœ¬è‰ç¶“ç–ã€‹é“ï¼šã€Œç´…éº´ï¼Œæ¶ˆé£Ÿå¥èƒƒèˆ‡ç¥éº´ç›¸åŒï¼Œè€Œæ´»è¡€å’Œå‚·å”¯ç´…éº´ç‚ºèƒ½ï¼Œæ•…æ²»è¡€ç—¢å°¤ç‚ºè¦è—¥ã€ã€‚

æ¸…ä»£æ±ªæ˜‚ã€Šæœ¬è‰å‚™è¦ã€‹ï¼šã€Œå…¥ç‡Ÿè€Œç ´è¡€ï¼Œç‡¥èƒƒæ¶ˆé£Ÿï¼Œæ´»è¡€å’Œå‚·ï¼Œæ²»èµ¤ç™½ç—¢ï¼Œè·Œæ‰“æå‚·ã€ã€‚æ±ªç´±ã€Šé†«æ—çº‚è¦ã€‹ï¼šã€Œè§£ç”Ÿå†·ç‰©æ¯’ã€ç­‰å‡æœ‰ç´…éº´è—¥æ•ˆä¹‹è¨˜è¼‰ã€‚

åœ¨å‚³çµ±è—¥ç”¨åŠŸæ•ˆä¸Šï¼Œè¢«èªç‚ºèƒ½æœ‰åŠ©æ–¼æ”¹å–„å¾ªç’°èˆ‡æ¶ˆåŒ–ç³»çµ±ã€‚ 

**æ‰€ä»¥ä»Šå¤©ä¸»è¦ä¾†è¨è«–çš„å°±æ˜¯ï¼š**

## **ç´…éº´ç‚ºä»€éº¼æœ‰æ•ˆï¼Ÿ**

æ—¥æœ¬æ±äº¬è¾²å·¥å¤§å­¸çš„**é è—¤ç« ** ï¼ˆãˆã‚“ã©ã†ã‚ãã‚‰ï¼‰æ•™æˆï¼Œæ–¼è¥¿å…ƒ 1979 å¹´å¾ç´…éº´èŒï¼ˆ _Monascus ruber_ ï¼‰åŸ¹é¤Šæ¶²ä¸­åˆ†é›¢å‡º Monacolin K å…·æŠ‘åˆ¶è†½å›ºé†‡åˆæˆæ´»æ€§ã€‚

è¥¿å…ƒ 1980 å¹´å­¸è€… Alberts ç­‰äººç™¼è¡¨ç ”ç©¶æŒ‡å‡ºå¾**åœŸéº´èŒ** ï¼ˆ _Aspergillus terrers_ ï¼‰ç™¼é…µæ¶²ä¸­ä¹Ÿèƒ½åˆ†é›¢å¾—åˆ° Mevinolinï¼Œè¥¿å…ƒ 1985å¹´æ—¥æœ¬å­¸è€…**é è—¤ç« ** ç­‰äººåˆåˆ†é›¢åˆ° Monacolin Lã€Xã€Jã€M ç­‰ç›¸åŒåŸºæœ¬çµæ§‹åŒ–åˆç‰©ï¼Œä¹Ÿéƒ½æœ‰é™ä½è†½å›ºé†‡ç”Ÿç‰©æ´»æ€§ã€‚

è€Œç¾åœ‹**ç´„ç‘Ÿå¤«ï¼è£æ­ç´å¾·ï¼æˆˆçˆ¾èŒ¨å¦** ï¼ˆJoseph L.Goldsteinï¼‰åŠ**éº¥å¯ï¼æ–¯åœ–äºç‰¹ï¼å¸ƒæœ—** ï¼ˆMichael S.Brownï¼‰æ•™æˆæ–¼è¥¿å…ƒ 1984 å¹´æˆåŠŸæ‰¾å‡º Monacolin K æŠ‘åˆ¶è†½å›ºé†‡åˆæˆä½œç”¨æ©Ÿè½‰ï¼Œä¸»è¦æ˜¯å®ƒèƒ½æŠ‘åˆ¶ç¾¥ç”²åŸºæˆŠäºŒé…°è¼”é…¶ A é‚„åŸé…¶ï¼ˆHMG-CoA Reductaseï¼‰çš„ä½œç”¨ï¼Œè€Œå¾Œéš”å¹´å…±åŒç²å¾—è«¾è²çˆ¾çã€‚

å…¶çµæ§‹èˆ‡è†½å›ºé†‡åˆæˆä¹‹é€Ÿç‡æ±ºå®šæ­¥é©Ÿæ‰€éœ€é…µç´  HMG-CoA reductase é‚„åŸé…¶çµæ§‹ç›¸ä¼¼ï¼Œæ•…æœƒèˆ‡ HMG-CoA Reductase ç”¢ç”Ÿç«¶çˆ­ï¼Œä½¿ Mevalonic Acid ç„¡æ³•å½¢æˆè€ŒæŠ‘åˆ¶é«”å…§è†½å›ºé†‡åˆæˆã€‚è‡ªæ­¤ä¹‹å¾Œï¼Œç´…éº´ï¼Œä¾¿å»£æ³›çš„è¢«é–‹ç™¼æˆå¥åº·ä¿å¥é£Ÿå“ã€‚ 

## **è†½å›ºé†‡çš„ç¨®é¡**

è†½å›ºé†‡ç”±ä¸åŒçš„ã€Œè¼‰é«”ã€ï¼ˆä¹Ÿç¨±ç‚ºè„‚è›‹ç™½ï¼‰æ”œå¸¶åˆ°å…¨èº«ï¼Œé«˜è†½å›ºé†‡æ²’æœ‰ä»»ä½•ç—‡ç‹€ï¼Œéœ€è¦é€²è¡Œè¡€æ¶²æª¢æŸ¥ä»¥ç¢ºå®šä½ æ˜¯å¦æ‚£æœ‰æ­¤ç—…ï¼Œé©—è¡€æœƒå‘Šè¨´ä½ è¡€æ¶²ä¸­ã€Œå¥½ã€å’Œã€Œå£ã€è†½å›ºé†‡çš„æ°´å¹³ã€‚

æœ€å¸¸è¦‹çš„å…©ç¨®æ˜¯ï¼š

  1. **ã€Œå£ã€è†½å›ºé†‡â€“ä½å¯†åº¦è„‚è›‹ç™½è†½å›ºé†‡** ï¼ˆLow density lipoprotein cholesterolï¼ŒLDL-Cï¼‰  
LDL è†½å›ºé†‡æ˜¯ã€Œå£çš„ã€ï¼Œå› ç‚ºå¦‚æœæ”å…¥éå¤šï¼Œå®ƒæœƒç²˜åœ¨å‹•è„ˆå£ä¸Šï¼Œæ­£å¸¸å€¼æ‡‰å°æ–¼ 160 mg/dl  

  2. **ã€Œå¥½ã€è†½å›ºé†‡â€“é«˜å¯†åº¦è„‚è›‹ç™½è†½å›ºé†‡** ï¼ˆHigh density lipoprotein cholesterolï¼ŒHDL-Cï¼‰  
HDL è†½å›ºé†‡æ˜¯ã€Œå¥½ã€çš„ï¼Œå› ç‚ºå®ƒå¯ä»¥æ¸…é™¤è¡€ç®¡ä¸­çš„ã€Œå£ã€è†½å›ºé†‡ï¼Œæ­£å¸¸å€¼æ‡‰è©²å¤§æ–¼ 35 mg/dl

ä¸‰é…¸ç”˜æ²¹è„‚æ˜¯é«”å…§æœ€å¸¸è¦‹çš„è„‚è‚ªå½¢å¼ï¼Œåœ¨è¡€æ¶²ä¸­å„²å­˜å’Œé‹è¼¸è„‚è‚ªã€‚

**é«˜ç¸½è¡€è†½å›ºé†‡** æ˜¯è¡¡é‡è¡€æ¶²ä¸­æ‰€æœ‰è†½å›ºé†‡å’Œä¸‰é…¸ç”˜æ²¹è„‚çš„æŒ‡æ¨™ï¼Œæ˜¯æ‚£å¿ƒè‡Ÿç—…çš„å±éšªå› ç´ ã€‚

## **ã€Œå£ã€è†½å›ºé†‡ç‚ºä»€éº¼å£**

æˆ‘å€‘çš„å™¨å®˜éƒ½éœ€è¦è¡€æ¶²ä¾›æ‡‰å……è¶³çš„æ°§æ°£å’Œé¤Šåˆ†æ‰èƒ½æ­£å¸¸é‹ä½œï¼Œç„¶è€Œè¡€æ¶²ä¸­çš„**ä½å¯†åº¦è†½å›ºé†‡** å¯èƒ½å †ç©åœ¨è¡€ç®¡å£å½¢æˆæ–‘å¡Šï¼Œå°è‡´å‹•è„ˆç²¥ç‹€ç¡¬åŒ–ï¼Œæ‰€ä»¥è¢«ç¨±ç‚ºã€Œå£è†½å›ºé†‡ã€ã€‚

æ´ªæƒ é¢¨é†«å¸«æŒ‡å‡ºï¼Œå¿ƒè‡Ÿçš„è¡€æ¶²ä¾›æ‡‰ä¾†è‡ªå† ç‹€å‹•è„ˆï¼Œå† ç‹€å‹•è„ˆç‹¹çª„åˆæœŸé€šå¸¸æ²’æœ‰ç—‡ç‹€ï¼Œä½†æ˜¯ç•¶å† ç‹€å‹•è„ˆç‹¹çª„çš„ç‹€æ³è¶Šä¾†è¶Šåš´é‡ï¼Œå¿ƒè‚Œä¾¿ç„¡æ³•ç²å¾—è¶³å¤ çš„è¡€æ¶²ä¾›æ‡‰ã€‚

éš¨è‘—è¡€ç®¡æ–‘å¡Šå¢åšï¼Œå† ç‹€å‹•è„ˆæœƒé€æ¼¸ç‹¹çª„ï¼Œä¸¦å°è‡´è¡€æµæ¸›å°‘ï¼Œç¨±ç‚ºç‹¹å¿ƒç—‡ã€‚

æ›´å¯æ€•çš„æ˜¯è¡€ç®¡æ–‘å¡Šçªç„¶ç ´è£‚ï¼Œå› ç‚ºè¡€ç®¡æ–‘å¡Šç ´è£‚æ™‚æœƒä¿ƒä½¿è¡€æ “å½¢æˆï¼Œè¡€æ “å¯èƒ½ä½¿è¡€ç®¡å®Œå…¨é˜»å¡ï¼Œè€Œé€ æˆå¿ƒè‚Œæ¢—å¡ã€‚

é™¤äº†é€ æˆå¿ƒè‚Œæ¢—å¡ä¹‹å¤–ï¼Œå‹•è„ˆç²¥ç‹€ç¡¬åŒ–é‚„å¯èƒ½é€ æˆè…¦ä¸­é¢¨ï¼Œå°è‡´åš´é‡å¾Œéºç—‡ã€‚

ç¶“éä¸€é€£ä¸²ç ”ç©¶ï¼Œç¾åœ‹**é»˜å…‹** åˆç¨±**é»˜æ²™æ±** ï¼ˆMerck Sharp & Dohmeï¼‰è—¥å» åœ¨è¥¿å…ƒ 1987 å¹´ä¸Šå¸‚çš„é™è¡€è„‚æ–°è—¥**ç¾ä¹è„‚** ï¼ˆMevacorï¼‰ï¼Œæ‰€å«æœ‰æ•ˆæˆåˆ† Lovastatin å³æ˜¯ä»¥ Monacolin K ç‚ºä¸»çš„é™ä½è¡€è†½å›ºé†‡è£½åŠ‘ç”¢å“ã€‚

æ—¥æœ¬**ç¬¬ä¸€ä¸‰å…±** ï¼ˆDaiichi Sankyoï¼‰è—¥å» çš„é™è¡€è„‚è—¥**ç¾ç™¾æ¨‚é®éŒ ** ï¼ˆMevalotinï¼‰ç‚ºè¥¿å…ƒ 1994 å¹´å…¨æ—¥æœ¬ç¬¬ä¸€å¤§æš¢éŠ·è—¥å“ï¼Œå…¶ä¸­æ‰€å«æœ‰æ•ˆæˆåˆ† Pravastatin å³æ˜¯ monacolin K çš„æ§‹é€ ï§ä¼¼ç‰©ã€‚

ä¸éåœ¨ç•¶æ™‚é‚„ä¸çŸ¥é“ Monacolin K è·Ÿ Lovastatin åŸºæœ¬ä¸Šå°±æ˜¯ç›¸åŒçš„åŒ–åˆç‰©ï¼Œå¾Œä¾†æ‰æœ‰ã€Œå°è¦ç±³èˆ‡å¤§é¯¨é­šã€çš„æ•…äº‹ï¼ˆå¾Œé¢æœ‰æ•˜è¿°ï¼‰ã€‚

## **èˆ‡ç´…éº´æœ‰é—œçš„ç ”ç©¶ï¼š**

### **ä¸€ã€é™è†½å›ºé†‡ã€é é˜²å¿ƒè¡€ç®¡ç–¾ç—…**

åœ¨è¥¿å…ƒ 2015 å¹´ä¸€ç¯‡è«–æ–‡æåˆ°ï¼Œåœ¨å° 20 é …**éš¨æ©Ÿå°ç…§è‡¨åºŠè©¦é©—** ï¼ˆRandomized Controlled Trialï¼ŒRCTï¼‰çš„çµ±åˆåˆ†æä¾†é©—è­‰äº†ç´…éº´çš„é™è¡€è„‚ä½œç”¨ï¼Œ åœ¨ 6,663 åå—è©¦è€…ä¸­ï¼Œç´…éº´æ¯å¤©ä½¿ç”¨åœ¨ 1,200 mg ~ 4,800 mg ä¹‹é–“ï¼ˆè£¡é¢å« Monacolin K 4.8 ~ 24 mgï¼‰çµ±è¨ˆåˆ†æé¡¯ç¤ºï¼Œèˆ‡å®‰æ…°åŠ‘ç›¸æ¯”ï¼š

  * **ä½å¯†åº¦è„‚è›‹ç™½è†½å›ºé†‡** ï¼ˆLow density lipoprotein cholesterolï¼ŒLDL-Cï¼‰é™ä½ç´„ 14.7% ï½ 48.2%ï¼›
  * **ä¸‰é…¸ç”˜æ²¹é…¯** ï¼ˆTriglycerideï¼ŒTGï¼‰é™ä½15% ï½ 46.3%ï¼›
  * **é«˜å¯†åº¦è„‚è›‹ç™½è†½å›ºé†‡** ï¼ˆHigh density lipoprotein cholesterolï¼ŒHDL-Cï¼‰å¢åŠ  0% ï½ 17.4%ã€‚
  * èˆ‡ä¸­ç­‰å¼·åº¦ Stain é¡è—¥ç‰©ï¼ˆPitavastatin 40 mgã€Simvastatin 10 mg å’Œ Lovastatin 20 mgï¼‰ç›¸æ¯”ï¼ŒLDL-C **é™ä½æ•ˆæœå·®ä¸å¤š** ã€‚

å…¶ä»–å­¸è€…åœ¨å…¶ä»–æœŸåˆŠç™¼è¡¨é¡¯ç¤ºç´…éº´ç„¡è«–å–®ç¨ä½¿ç”¨ç´…éº´æˆ–åˆä½µå…¶ä»–ç”¢å“ä½¿ç”¨ï¼Œéƒ½ä¸æœƒå¢åŠ é«˜è¡€è„‚ç—‡æ‚£è€…ç™¼ç”Ÿä¸è‰¯äº‹ä»¶çš„é¢¨éšªã€‚

æ ¹æ“šå°ç£è¡›ç”Ÿç¦åˆ©éƒ¨å…¬å¸ƒçš„ã€Šç´…éº´å¥åº·é£Ÿå“è¦æ ¼æ¨™æº–ã€‹ï¼Œè‡ªç´…éº´å¥åº·é£Ÿå“æ‰€æ”å–çš„ Monacolin Kï¼Œ**æ¯æ—¥è‡³å°‘æ‡‰é”åˆ° 4.8 æ¯«å…‹ä»¥ä¸Šï¼Œä½†ä¸å¾—è¶…é 15 æ¯«å…‹** ã€‚

### **äºŒã€é™è¡€å£“**

è¥¿å…ƒ 1986 å¹´å­¸è€…**è¾» å•“ä»‹** åœ¨æ—¥æœ¬è¾²æ¥­åŒ–å­¸å­¸æœƒæœƒè­°ä¸ŠæŒ‡å‡ºï¼Œé•·æœŸæœç”¨ç´…éº´å¯æ¸›å°‘**å…ˆå¤©æ€§é«˜è¡€å£“è€é¼ ** ï¼ˆSpontaneous Hypertension Ratsï¼‰è¡€å£“å‡é«˜ï¼›

è¥¿å…ƒ 1987 å¹´å­¸è€… Kohama ç­‰äººç™¼ç¾å…¶ä¸­ä¹‹é™è¡€å£“ç‰©è³ªç‚ºç´…éº´ç”¢ç”Ÿçš„ **Î³-èƒºåŸºä¸é…¸** ï¼ˆÎ³-Aminobutyric acidï¼ŒÎ³-GABAï¼‰å’Œ**ä¹™é†¯è†½é¹¼** ï¼ˆAcetylcholineï¼‰ï¼›

è¥¿å…ƒ 1992 å¹´å­¸è€…**è¾» å•“ä»‹** ç­‰äººåœ¨æ—¥æœ¬ç‡Ÿé¤Šå­¸é›œèªŒç™¼è¡¨æŒ‡å‡ºåœ¨é£¼æ–™æ·»åŠ  0.2 ï½ 0.3ï¼… ç´…éº´åŸ¹é¤Šç‰©å¯ä½¿æ‚£æœ‰å…ˆå¤©é«˜è¡€å£“ç—‡è€é¼ ä¹‹è¡€å£“ç”±è¶…é 200 mmHg é™è‡³ 180 mmHg ä»¥ä¸‹ï¼›è¥¿å…ƒ 1995 å¹´æ—¥æœ¬å­¸è€…**äº•ä¸Š æ¸…** ç™¼è¡¨è®“åœ¨é†«é™¢è£¡çš„é«˜è¡€å£“æ‚£è€…ä½¿ç”¨é«˜æ¿ƒï¨ GABA çš„ä¿å¥ç´…éº´ï¼Œèƒ½ä½¿ç™½å¤©æ´»å‹•æ™‚æ®µæœ€é«˜è¡€å£“æœƒè¶…é 180 mmHg çš„æ‚£è€…ï¨‰è‡³ 160 mmHg ä»¥ä¸‹ã€‚

### **å…¶ä»–å„é …å¥½è™•**

ç›®å‰ç´…éº´é‚„æœ‰è¨±å¤šå…·åŠŸæ•ˆçš„ç‰©è³ªï§“çºŒè¢«ç™¼ç¾ï¼Œï¦µå¦‚å…·é˜²ç™Œçš„ Ankaflavinã€èƒ½ä¿è­·è‚è‡Ÿèˆ‡æ¸…é™¤æ°§åŒ–ç‰©è³ª Dimerumic Acid ï¼Œä»¥åŠå¦‚ï¨‰è¡€ï¨ƒã€æŠ—ç–²ï¤¯ã€æ”¹å–„é˜¿èŒ²ç½•é»˜ç—‡ï§æ¾±ç²‰è›‹ç™½æ²‰ç©æ‰€é€ æˆçš„è¨˜æ†¶ã€å­¸ç¿’èƒ½ï¦Šä¸‹ï¨‰ã€é é˜²é«˜è„‚é£²é£Ÿæ‰€é€ æˆä¹‹è‚¥èƒ–ç­‰ç­‰çš„ç ”ç©¶ã€‚

å¦å¤–ï¼Œåœ¨é¤µé£Ÿç´…éº´ç±³çš„æ¯é›ç™¼ç¾å¯ï¨‰ä½å…¶é›è›‹ã€é›è‚‰ä¸­è†½å›ºé†‡å«ï¥¾ã€‚

## **ç´…éº´ç™¼é…µæŠ€è¡“**

å‚³çµ±çš„ç´…éº´è£½ä½œéœ€è¦å°‡ç³¯ç±³æµ¸æ³¡åœ¨æ°´ä¸­ä¸€å¤©ï¼Œç„¶å¾Œç…®ç†Ÿã€‚å› ç‚ºç´…éº´èŒå—œé…¸æ€§ï¼Œå› æ­¤åœ¨ç¨®[](https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/vinegar)èŒä¹‹å‰å…ˆç”¨é†‹æˆ–æ˜ç¤¬æº¶æ¶²é…¸åŒ–ç±³ã€‚ç„¶å¾Œé™„è‘—æ–¼ç±³ä¸Šåœ¨ 33 ï½ 42 Â°C ä¸‹åŸ¹é¤Š 2 é€±ã€‚

ç”±æ–¼ç´…éº´èŒèˆ‡å…¶ä»–å¾®ç”Ÿç‰©ç›¸æ¯”ï¼Œå…¶ç”Ÿé•·é€Ÿåº¦å’Œç”¢ç”Ÿå­¢å­çš„èƒ½åŠ›éƒ½è¼ƒå·®ï¼Œä½¿å¾—å‚³çµ±ç´…éº´ç”Ÿç”¢æŠ€è¡“è¼ƒè²»åŠŸå¤«ï¼Œç±³å¯èƒ½æœƒå—åˆ°ç’°å¢ƒå’Œæ‰‹å·¥ç¿»å‹•çš„æ±¡æŸ“ã€‚æ”ªæ‹Œå’Œæµ¸æ°´çš„äººå·¥æˆæœ¬è¼ƒé«˜ã€‚

ç›®å‰ç´…éº´ç™¼é…µç”Ÿç”¢ç ”ç©¶ï¼Œä¸å¤–ä¹ä½¿ç”¨æ¶²æ…‹æˆ–å›ºæ…‹ä¹‹ç™¼é…µæ³•ï¼›

### **å›ºæ…‹ç™¼é…µï¼ˆSolid-State Fermentationï¼ŒSSFï¼‰**

å›ºæ…‹ç™¼é…µè£½ç¨‹æ˜¯æŒ‡åˆ©ç”¨å›ºæ…‹çš„åŸºè³ªï¼Œåœ¨æœ‰é™çš„å«æ°´é‡ä¸‹é€²è¡Œå¾®ç”Ÿç‰©åŸ¹é¤Šã€‚ä¹Ÿå¯ä»¥ç”¨å…¶ä»–çš„ç‰©è³ªåšç‚ºåŸºè³ªï¼ŒåŒ…å«éºµåŒ…ã€éº©çš® ã€å…¶ä»–ç©€ç‰©æˆ–è¾²æ¥­å»¢æ£„ç‰©ã€‚å›ºæ…‹åŸºè³ªå…·æœ‰**å¤šå­”æ€§** ï¼ˆPorosityï¼‰ï¼Œæœ‰åˆ©ç´…éº´èŒçµ²ç”Ÿé•·æ”€é™„å’Œç©¿é€ã€‚

é€šå¸¸ä½¿ç”¨åœ¨ä¾†ç±³ä½œç‚ºåŸ¹é¤Šç´…éº´ï¼Œå…¶ç›´éˆæ¾±ç²‰å«é‡é«˜é” 70 %ï¼Œé»æ€§ä½ä¸”å®¹æ˜“å¸æ”¶æ°´åˆ†ã€‚ç¶“é 8 ~10 å¤©çš„ç™¼é…µå¾Œå…¶æ¾±ç²‰å«é‡æœƒé€æ¼¸æ¸›å°‘ï¼Œè€Œè›‹ç™½è³ªèˆ‡è„‚è³ªå«é‡æœƒä¸Šå‡ï¼Œä¸¦ç”¢ç”Ÿè‰²ç´ åŠå…¶ä»–æ¬¡ç´šä»£è¬ç‰©ã€‚

ä»¥å›ºæ…‹ç™¼é…µæ–¹å¼åŸ¹é¤Šç´…éº´çš„å„ªé»ç‚ºè¼ƒæ¥è¿‘å¤©ç„¶ç”Ÿé•·çš„ç’°å¢ƒã€ç”Ÿç”¢æˆæœ¬ä½ã€è¨­å‚™éœ€æ±‚ä¸é«˜ã€æ˜“ç®¡ç†ã€ç”¢å‡ºå»¢æ°´å°‘å’Œä»£è¬ç‰©æ¿ƒåº¦è¼ƒé«˜ï¼Œåœ¨å°è¦æ¨¡çš„ç”Ÿç”¢ä¸Šå…·æœ‰çµ•å°çš„å„ªå‹¢ã€‚ä½†å›ºæ…‹ç™¼é…µæ‰€éœ€çš„**åŸ¹é¤Šæ™‚é–“è¼ƒé•·** ã€**ä¸æ˜“æ”¾å¤§ç”Ÿç”¢** åŠ**åŸ¹é¤Šç’°å¢ƒå› å­æ§åˆ¶è¼ƒå›°é›£** ï¼Œä¸”**å®¹æ˜“å—åˆ°å…¶ä»–çœŸèŒæˆ–ç´°èŒæ±™æŸ“** ã€‚

### **æ¶²æ…‹æ·±å±¤ç™¼é…µï¼ˆ Submerged Fermentationï¼ŒSmFï¼‰**

ç´…éº´å‚³çµ±æ¶²æ…‹ç™¼é…µçš„å…¸å‹ä¾‹å­ç‚ºç´…éœ²é…’-å°‡ç´…éº´èˆ‡é…µæ¯èŒå…±åŒåŸ¹é¤Šç™¼é…µï¼Œç”¢ç”Ÿå…·ç¨ç‰¹é¦™æ°£åŠé¢¨å‘³çš„é‡€é€ é…’ã€‚

ç›¸è¼ƒæ–¼å‚³çµ±å›ºæ…‹å¼ç™¼é…µï¼Œé›–ç„¶æ¶²æ…‹ç™¼é…µæ‰€éœ€çš„ç”Ÿç”¢è¨­å‚™æˆæœ¬è¼ƒé«˜ï¼Œä½†å¯ä»¥å°è£½ç¨‹åƒæ•¸é€²è¡Œå¤šæ¨£çš„æœ‰æ•ˆæ§åˆ¶ï¼Œç¢ºå¯¦æŒæ¡ä»£è¬ç‰©é€”å¾‘çš„é€²è¡Œæ–¹å‘ï¼Œé©åˆå®šå‘ç”Ÿç”¢ã€‚æ¶²æ…‹ç™¼é…µçš„ç¼ºé»ç‚ºç´…éº´èŒé«”å’Œä»£è¬ç‰©æ¿ƒåº¦è¼ƒå›ºæ…‹ç™¼é…µç‚ºä½ï¼Œä¸”**æœ‰å»¢æ°´è™•ç†** èˆ‡**ç”¢ç‰©å›æ”¶ä¸æ˜“** ç­‰å•é¡Œã€‚

ç›®å‰å» å•†**å¤šä»¥å›ºæ…‹ç™¼é…µç”Ÿç”¢** ï¼Œå› ç‚ºä»¥å›ºæ…‹åŸ¹é¤Šç™¼é…µç”Ÿç”¢ç´…éº´å¯ç”Ÿæˆè¼ƒé«˜é‡çš„ Monacolin Kï¼Œè€Œæ¶²æ…‹åŸ¹é¤Šä¹‹ Monacolin K ç”Ÿæˆé‡è¼ƒå°‘ï¼›

å¦å¤–å›ºæ…‹åŸ¹é¤Šç”¢ç”Ÿçš„æ©˜é»´ç´ æ¯”æ¶²æ…‹åŸ¹é¤Šä½ 1000 å€ï¼ˆåˆ†åˆ¥ç‚º 0.018 Î¼g/g å’Œ 19.02 Î¼g/gï¼‰ã€‚

åœ¨å¤§å¤šæ•¸äºæ´²åœ‹å®¶ï¼Œç´…éº´é€šå¸¸æ¡ç”¨å‚³çµ±æ–¹æ³•ç”Ÿç”¢ã€‚éå»åœ¨ç™¼é…µéç¨‹ä¸­é¢è‡¨çš„äººåŠ›å•é¡Œï¼Œä»¥åŠåŸ¹é¤Šéœ€è¼ƒå¤§é¢ç©ã€é«˜é›£åº¦æ“ä½œæŠ€å·§ã€å“è³ªæ§åˆ¶ä¸æ˜“ç­‰å•é¡Œï¼Œéƒ½ç”±æ–¼ç™¼å±•å‡ºæ–°ç© e åŒ–è¨­è¨ˆçš„å¤§å‹å›ºæ…‹ç™¼é…µæ§½è¿åˆƒè€Œè§£äº†ã€‚

å› ç‚ºç”Ÿç”¢æµç¨‹æ©Ÿæ¢°åŒ–ï¼Œå¯ä»¥æŒæ¡åŸ¹é¤Šç’°å¢ƒå› ç´ ï¼Œæ§åˆ¶æº«åº¦ä¸”å¯é©æ™‚çµ¦æ°´ï¼Œç¸®çŸ­åŸ¹é¤Šæ™‚é–“å’ŒåŸ¹é¤Šæ™‚æ¸›å°‘æ±¡æŸ“æ©Ÿæœƒï¼Œä½¿å¾—ç”¢å“ç´”åº¦æé«˜ä¸”å“è³ªå‡ä¸€ã€‚

## **æ©˜é»´ç´ æ˜¯ä»€éº¼**

çœŸèŒé¡æœƒåˆ©ç”¨æ¤ç‰©é«”è¡¨é¢çš„å‚·å£æˆ–æå‚·å…¥ä¾µæ¤ç‰©å¤–ï¼Œä¹Ÿæœƒç”¢ç”Ÿ**é…µç´ ** ã€**æ¯’ç´ ** ã€**ç”Ÿé•·èª¿ç¯€åŠ‘** ç­‰åŒ–å­¸ç‰©è³ªå”åŠ©çœŸèŒé«”å¯„ç”Ÿæ–¼æ¤ç‰©é«”ï¼Œå¯ä»¥å½±éŸ¿æ¤ç‰©ç´°èƒçš„ç‰¹å®šç”Ÿç†æ©Ÿèƒ½ï¼Œé€ æˆæ¤ç‰©ç—…å®³åŠ åŠ‡ã€‚

æ©˜é»´ç´ ï¼ˆCitrininï¼‰å¯ç”±éº´èŒå±¬ã€é’é»´èŒå±¬ã€ç´…éº´èŒå±¬ç­‰é»´èŒç”¢ç”Ÿï¼Œå¤§å¤šä¼´éš¨ç´…è‰²ç´ çš„ç”Ÿæˆè€Œç”¢ç”Ÿï¼›æ©˜é»´ç´ å¯æŠ‘åˆ¶é©è˜­æ°é™½æ€§èŒå¦‚éˆçƒèŒã€èŠ½å­¢æ¡¿èŒç­‰é£Ÿç‰©è…æ•—èŒçš„ç”Ÿé•·ï¼Œå› æ­¤å¤äººä¹Ÿç”¨ä¾†åšç‚ºè‚‰å“çš„é˜²è…åŠ‘ã€‚

å°èŒå¥½ä½†æ˜¯å°ä½ ä¸å¥½

å°äººé«”çš„è…è‡Ÿæœ‰æ¯’å®³ä½œç”¨ï¼Œå¯å¼•èµ·è…è‡Ÿè…«ã€å°¿é‡å¢å¤šã€è…å°ç®¡æ“´å¼µã€ä¸Šçš®ç´°èƒè®Šæ€§å£æ­»ï¼Œæ‰€ä»¥ä¹Ÿç¨±ç‚ºè…æ¯’ç´ ã€‚

æ”¹å–„ç™¼é…µæ¢ä»¶ä¹Ÿæ˜¯æ§åˆ¶æ©˜é»´ç´ çš„æ–¹æ³•ä¹‹ä¸€ï¼Œå¦‚èª¿é…åŸ¹é¤ŠåŸºçš„æˆä»½ï¼ˆé™ä½æ°®æºå«é‡ä¸¦æé«˜ç¢³æºå«é‡ï¼‰ï¼Œå¯æ”¹è®Šæ©˜é»´ç´ ç”Ÿæˆçš„ä»£è¬è·¯å¾‘ï¼Œå¯é™ä½æ©˜é»´ç´ çš„ç”Ÿæˆï¼›æˆ–æ˜¯å°‡ç™¼é…µç’°å¢ƒçš„ pH å€¼æ§åˆ¶åœ¨ 4.5 ä»¥ä¸‹ï¼Œä¹Ÿèƒ½æœ‰æ•ˆæŠ‘åˆ¶æ©˜é»´ç´ çš„ç”Ÿæˆã€‚

ä¾ç…§è¡›ç”Ÿç¦åˆ©éƒ¨é£Ÿå“è—¥ç‰©ç®¡ç†æ³•ç¬¬ä¸‰åå…«æ¢åº•ä¸‹ã€Œé£Ÿå“ä¸­çœŸèŒæ¯’ç´ é™é‡æ¨™æº–ã€è¦å®šï¼Œæ©˜é»´ç´ çš„é™é‡åœ¨**ç´…éº´è‰²ç´ ç‚º 200 ppb ä»¥ä¸‹ï¼ŒåŸæ–™ç”¨ç´…éº´ç±³ç‚º 5 ppm ä»¥ä¸‹ï¼Œä½¿ç”¨ç´…éº´åŸæ–™è£½æˆä¹‹é£Ÿå“ç‚º 2 ppm ä»¥ä¸‹** ã€‚

## **ç´…éº´å‰¯ä½œç”¨ï¼š**

ç›®å‰è¢«å ±å°éçš„å‰¯ä½œç”¨ä¸»è¦æ˜¯èƒƒè…¸é“ï¼Œå¦‚èƒƒç—›ã€è„¹æ°£ç­‰å•é¡Œã€‚å¦‚æœæœ‰ç™¼ç”Ÿä¸Šè¿°ç‹€æ³ï¼Œè«‹**æ¸›é‡ä½¿ç”¨æˆ–æš«æ™‚åœæ­¢ä½¿ç”¨ï¼Œä¸¦ä¸”å°‹æ±‚å”åŠ©ã€‚**

## **æ³¨æ„äº‹é …ï¼š**

  * **ç”±æ–¼ç´…éº´ä¸­çš„ Monacolin K çš„çµæ§‹ä»¥åŠé™è†½å›ºé†‡çš„æ©Ÿåˆ¶ï¼Œèˆ‡é†«å¸«å¸¸é–‹çš„é™è†½å›ºé†‡ Statin é¡çš„è—¥ç‰©å¯èªªæ˜¯é«˜åº¦é‡ç–Šï¼Œå› æ­¤å·²ç¶“æœ‰æœç”¨ Statin é¡è—¥ç‰©æ‚£è€…ä¸è¦è£œå……ç´…éº´ä¿å¥å“ã€‚**
  * **å¦å¤–å¦‚æœä½ æ˜¯æ…¢æ€§ç—…æ‚£è€…ï¼Œè«‹åœ¨é£Ÿç”¨ç´…éº´ä¿å¥å“å‰è«®è©¢é†«ç”Ÿï¼Œä»¥ç¢ºä¿å®‰å…¨ã€‚**

## **å¦‚ä½•æŒ‘é¸ç´…éº´ç”¢å“ï¼š**

### **ã„§ã€æŒ‘é¸å«æœ‰ Monacolin K çš„æœ‰æ•ˆæˆåˆ†**

ç´…éº´çš„æˆåˆ†ä¸­ï¼Œæœ€å»£ç‚ºäººçŸ¥çš„å°±æ˜¯ç´…éº´èŒç¨®ç™¼é…µç”¢ç”Ÿçš„**è«é‚£å¯æ—** (Monacolin K)ï¼Œå› ç‚ºå®ƒèˆ‡**å²ä»–æ±€** ï¼ˆStatinï¼‰çš„çµæ§‹ç›¸ä¼¼ï¼Œç ”ç©¶é¡¯ç¤ºå¯èƒ½æœ‰åŠ©æ–¼é™ä½è¡€ä¸­ç¸½è†½å›ºé†‡çš„å«é‡ã€‚

æ ¹æ“šå°ç£è¡›ç”Ÿç¦åˆ©éƒ¨å…¬å¸ƒçš„ã€Šç´…éº´å¥åº·é£Ÿå“è¦æ ¼æ¨™æº–ã€‹ï¼Œè‡ªç´…éº´å¥åº·é£Ÿå“æ‰€æ”å–çš„ Monacolin Kï¼Œæ¯æ—¥è‡³å°‘æ‡‰é”åˆ° 4.8 æ¯«å…‹ä»¥ä¸Šï¼Œä½†ä¸å¾—è¶…é 15 æ¯«å…‹ã€‚

### **äºŒã€æ©˜é»´ç´ çš„å«é‡**

ç´…éº´è‹¥æ˜¯ç™¼é…µéç¨‹è™•ç†ä¸ç•¶ï¼Œæ©˜é»´ç´ å¾ˆå®¹æ˜“è¶…æ¨™ã€‚é£Ÿè—¥ç½²æ›¾æŠ½é©—å°ç£ 199 ä»¶ç´…éº´ç”¢å“ï¼Œä¸¦æœªæª¢å‡ºæ±¡æŸ“çš„æ©˜é»´ç´ ã€‚

ç›®å‰ç´…éº´ä¿å¥å“çš„è¦ç¯„ä¸­ï¼Œæ©˜é»´ç´ çš„æ—¥æ”å–é‡æ‡‰å°æ–¼ **2ppm** ä»¥ä¸‹ï¼Œå› æ­¤é¸è³¼æ™‚å»ºè­°çœ‹æ¸…æ¨™ç¤ºï¼Œæˆ–æ˜¯ç›´æ¥è©¢å•å•†å®¶æ©˜é»´ç´ çš„å«é‡æˆ–æª¢é©—å ±å‘Šã€‚

### **ä¸‰ã€æ¡ç”¨çš„ç™¼é…µæŠ€è¡“**

ç›®å‰è¼ƒå¸¸è¦‹çš„æŠ€è¡“æ˜¯ã€Œå›ºæ…‹é†±é…µã€æ³•ï¼Œå›ºæ…‹ç™¼é…µç´…éº´ç±³èƒ½å¤ ä¿ç•™è¼ƒå®Œæ•´çš„ç‡Ÿé¤ŠåŠæ´»æ€§æˆåˆ†ä¸¦æ¸›å°‘æ©˜é»´ç´ çš„ç”¢ç”Ÿã€‚

### **å››ã€æ˜¯å¦æœ‰å¥åº·é£Ÿå“èªè­‰**

æœ‰ç¬¬ä¸‰æ–¹å–®ä½ä¾†å¹«å¿™æŠŠé—œå•†å“ï¼Œå¦‚ SGS å¯æª¢é©—æ˜¯å¦å«é‡é‡‘å±¬ã€è¥¿è—¥ã€è¾²è—¥ç­‰ï¼Œè£½é€ å•†ä¹Ÿé ˆé€šé HACCPã€ISO22000 ç­‰é©—è­‰ï¼ŒåŒæ™‚æœ€å¥½ä¸å«æ©˜é»´æ¯’ç´ ã€ä¸ç”¨ç´…éº´è‰²ç´ ï¼Œæ‰ä¸æœƒå°èº«é«”é€ æˆè² æ“”ã€‚

è·¯é‚Šè²©è³£çš„ç´…éº´è£½å“ï¼Œå¤šæ•¸ç‚ºç´…éº´é¢¨å‘³é£Ÿå“ï¼Œä¸¦ä¸è¦‹å¾—æœ‰æ‰€å…¶å®£ç¨±çš„æ•ˆæœï¼›å¦‚æœèƒ½æ‹¿åˆ°ä¿—ç¨±å°ç¶ äººçš„ã€Œå¥åº·é£Ÿå“ã€æ¨™ç« ï¼Œé€šå¸¸æœƒæ‹¿åˆ°çš„æ˜¯ã€Œ**èª¿ç¯€è¡€è„‚** ã€çš„èªè­‰ï¼Œä¹Ÿæ˜¯é¸æ“‡çš„é‡è¦åƒè€ƒæŒ‡æ¨™ã€‚

## **æ¨è–¦â€“â€“å¦‚æ–°ç´…éº´æ¸…é†‡è† å›Š**

### **é›™ç›²ç ”ç©¶**

åœ¨è¥¿å…ƒ 1999 å¹´ç™¼è¡¨åœ¨ç¾åœ‹è‡¨åºŠç‡Ÿé¤ŠæœŸåˆŠç ”ç©¶ï¼Œæ‰¾ä¾† 83 ä½ï¼ˆ46 ä½ç”·æ€§å’Œ 37 ä½å¥³æ€§ï¼‰å—è©¦è€…é€²è¡Œçš„**éš¨æ©Ÿã€é›™ç›²ã€å®‰æ…°åŠ‘å°ç…§** ç ”ç©¶ã€‚æ²»ç™‚ 8 é€±å¾Œèˆ‡å°ç…§çµ„æ¯”è¼ƒï¼Œæ¯å¤©æœç”¨ 2.4 å…‹ç´…éº´ï¼ˆå« 9.6 æ¯«å…‹ Monacolinsï¼‰çš„äºº**è†½å›ºé†‡** å¾ 254 mg/dL é™è‡³ 208 mg/dLï¼ˆ17 %ï¼‰ï¼Œ **ä½å¯†åº¦è„‚è›‹ç™½è†½å›ºé†‡** ï¼ˆLow density lipoprotein cholesterolï¼ŒLDL-Cï¼‰å¾ 175 mg/dL ä¸‹é™è‡³ 135 mg/dL (22%)ï¼Œ**ä¸‰é…¸ç”˜æ²¹è„‚** ï¼ˆTriglycerideï¼ŒTGï¼‰ å¾ 146 mg/dL ä¸‹é™è‡³ 124 mg/dL (12%)ï¼Œè€Œ**é«˜å¯†åº¦è„‚è›‹ç™½è†½å›ºé†‡** ï¼ˆHigh density lipoprotein cholesterolï¼ŒHDL-Cï¼‰ä¿æŒä¸è®Šã€‚

å…©çµ„åœ¨ç¸½ç†±é‡ã€ç¸½è„‚è‚ªã€é£½å’Œè„‚è‚ªã€å–®å…ƒä¸é£½å’Œè„‚è‚ªã€å¤šå…ƒä¸é£½å’Œè„‚è‚ªæˆ–çº–ç¶­æ–¹é¢æ²’æœ‰é¡¯è‘—å·®ç•°ã€‚æ²’æœ‰å ±å‘Šè‚åŠŸèƒ½åƒæ•¸è®ŠåŒ–æˆ–å…¶ä»–åš´é‡ä¸è‰¯äº‹ä»¶ã€‚

### **ç„¡æ©˜é»´ç´ æ®˜ç•™**

è¥¿å…ƒ 2001 å¹´ç™¼è¡¨åœ¨æœŸåˆŠä¸Šï¼Œä½œè€…è³¼è²·äº†ä¹ç¨®ä¸åŒçš„å¸‚å”®ç´…éº´è†³é£Ÿè£œå……åŠ‘ä¾†æ¸¬è©¦å…¶åŒ–å­¸æˆåˆ†ï¼›ä»¥é«˜æ•ˆæ¶²ç›¸å±¤æ (HPLC) æ¸¬é‡ Monacolin K ï¼Œç”¨æ”¾å°„å…ç–«æ¸¬å®šæ³•é€²è¡Œæ¸¬é‡æ©˜é»´ç´ ã€‚

çµæœ**å¦‚æ–°ç´…éº´æ¸…é†‡è† å›Š** æ¯é¡†è‡³å°‘å« 2.4 æ¯«å…‹ Monacolin K ä¸”æ¸¬ä¸åˆ°æ©˜é»´ç´ ã€‚

### **å›ºæ…‹ç™¼é…µ**

å¤§å¤šæ•¸äºæ´²åœ‹å®¶ï¼Œç´…éº´é€šå¸¸æ¡ç”¨å›ºæ…‹ç™¼é…µç”Ÿç”¢ã€‚

### **å¥åº·é£Ÿå“èªè­‰**

ç›®å‰ä¾æ“šã€Œç´…éº´å¥åº·é£Ÿå“è¦æ ¼æ¨™æº–ã€ï¼Œ**ç´…éº´å·²ç¶“è¢«åˆ—ç‚ºç¬¬äºŒè»Œçš„å¥åº·é£Ÿå“ä¹‹ä¸€** ï¼Œå› æ­¤å¦‚æœç´…éº´ç”¢å“ç¬¦åˆè©²è¦æ ¼çš„è¦ç¯„ï¼Œå«æœ‰è¶³å¤ çš„ç´…éº´æœ‰æ•ˆæˆåˆ† Monacolin Kï¼Œç¶“å¯©æŸ¥é€šéå°±å¯å®£ç¨±ã€Œæœ¬ç”¢å“å¯èƒ½æœ‰åŠ©æ–¼é™ä½è¡€ä¸­ç¸½è†½å›ºé†‡ï¼›å…¶åŠŸæ•ˆç”±å­¸ç†å¾—çŸ¥ï¼Œéç”±å¯¦é©—ç¢ºèªã€ã€‚

ç¬¬äºŒè»Œçš„ç”¢å“ä¸Šæ¨™æœ‰ã€Œè¡›ç½²å¥é£Ÿè¦å­—ç¬¬000000è™Ÿã€ï¼Œä¸¦ä¸”å¤šäº†ä¸€å€‹ã€Œè¦ã€å­—ï¼Œæ•¸å­—ç‚º 6 ç¢¼ï¼Œä¸å«è‹±æ–‡å­—æ¯ï¼Œè€Œç¬¬ä¸€è»Œçš„ç”¢å“ä¸Šæ¨™æœ‰ã€Œ**è¡›ç½²å¥é£Ÿå­—ç¬¬A00000è™Ÿ** ã€ï¼ŒåŒ…å« 1 å€‹è‹±æ–‡å­—æ¯ A åŠ 5 å€‹é˜¿æ‹‰ä¼¯æ•¸å­—ï¼›

è¦æ‹¿é£Ÿå­—è™Ÿç¬¬ä¸€è»Œç‚ºã€Œå€‹æ¡ˆå¯©æŸ¥ã€ï¼šç”¢å“éœ€åŸ·è¡Œå®‰å…¨æ€§ã€åŠŸæ•ˆæ€§åŠå®‰å®šæ€§è©¦é©—ï¼Œç¶“è¡›ç”Ÿç¦åˆ©éƒ¨å¯©æŸ¥è©•ä¼°ç”¢å“å®‰å…¨ç„¡è™ä¸¦å…·ä¿å¥åŠŸæ•ˆï¼Œå§‹å–å¾—å¥åº·é£Ÿå“è¨±å¯è­‰ã€‚**å¦‚æ–°ç´…éº´æ¸…é†‡è† å›Š** å¯æ˜¯ç²å¾—ç¬¬ä¸€è»Œé£Ÿå­—è™Ÿçš„ã€Œ[è¡›ç½²å¥é£Ÿå­—ç¬¬A00004è™Ÿ](https://consumer.fda.gov.tw/Food/InfoHealthFoodDetail.aspx?nodeID=162&id=4)ã€å–”ï¼

å¯å®£ç¨±ï¼š

  * æœ‰åŠ©æ–¼é™ä½è¡€ä¸­ç¸½è†½å›ºé†‡ã€‚ 
  * æœ‰åŠ©æ–¼é™ä½è¡€ä¸­ä½å¯†åº¦è„‚è›‹ç™½è†½å›ºé†‡ã€‚ 
  * æœ‰åŠ©æ–¼æ¸›å°‘ç™¼ç”Ÿè…¦å¿ƒè¡€ç®¡ç–¾ç—…çš„å±éšªå› å­ã€‚

è³¼è²·é€£çµï¼šğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

**[å¦‚æ–°ç´…éº´æ¸…é†‡è† å›Šï¼ˆ120é¡†ï¼‰](https://www.nuskin.com.tw/shop/poSharePdp/1176341658270290920?salesSlipId=1370178882975823888&catalogId=1218158942778210389&openExternalBrowser=1&utm_source=copylink&utm_medium=affiliate&utm_campaign=personal-offer)**

## **å°è¦ç±³å°æŠ—å¤§é¯¨é­šçš„å°æ•…äº‹**

Pharmanex æ¨å‡ºçš„**ç´…éº´æ¸…é†‡è† å›Š** ï¼Œç”±æ–¼èƒ½æœ‰æ•ˆé™ä½è†½å›ºé†‡åŠä¸‰é…¸ç”˜æ²¹è„‚ï¼Œå°é˜²æ²»å¿ƒè¡€ç®¡ç–¾ç—…æœ‰æ˜é¡¯åŠŸæ•ˆï¼Œè€Œä¸”æ²’æœ‰ä½¿ç”¨è—¥ç‰©æ‰€é€ æˆè‚Œè‚‰é…¸ç—›çš„å‰¯ä½œç”¨ã€‚æ¨å‡ºä¸åˆ°ä¸€å¹´ï¼Œå°±æ“ é€²å…¨ç¾å¹´åº¦æš¢éŠ·ç‡Ÿé¤Šè£œçµ¦å“å‰ 20 åï¼Œå› è€Œä¹Ÿå¼•èµ·è«¸å¤šå¤§è—¥å» é—œæ³¨ã€‚

ç¾åœ‹é»˜å…‹è—¥å» éŠ·å”®ä¸€æ¬¾è—¥å“ Mevacorï¼ˆMevacor çš„æ´»æ€§è—¥ç‰©æˆåˆ†å°±æ˜¯ Lovastatinï¼‰ï¼ŒPharmanex é€™æ¬¾ç”¢å“å½±éŸ¿åˆ°æ­¤è—¥çš„éŠ·å”®é‡ã€‚æ‰€ä»¥é»˜å…‹è—¥å» å‘é£Ÿå“è—¥ç‰©ç®¡ç†å±€ï¼ˆFDAï¼‰æå‡ºã€ŒPharmanex çš„ç´…éº´æ¸…é†‡è† å›Šç©¶ç«Ÿæ‡‰ä»¥è—¥å“æˆ–ç‡Ÿé¤Šè£œå……å“åˆ—ç®¡ï¼Ÿã€çš„è³ªç–‘ï¼Œç©¶ç«Ÿæ‡‰ä»¥ä¸€èˆ¬ç‡Ÿé¤Šå“ä¸Šæ¶ï¼Ÿäº¦æˆ–é€éé†«é™¢ã€è—¥å±€ç­‰ç”±è—¥å¸«å°ˆæ¥­æŠŠé—œçš„é€šè·¯è²©è³£ï¼Ÿ

FDA é–‹å§‹å°**ç´…éº´æ¸…é†‡è† å›Š** å±•é–‹èª¿æŸ¥ï¼Œä¹Ÿè®“æ­£è¦èµ·æ­¥çš„ Pharmanex é™·å…¥å®˜å¸çºè¨Ÿã€‚é›–ç„¶**ç´…éº´æ¸…é†‡è† å›Š** ä¸è«–åœ¨å“è³ªã€å®‰å…¨æ€§åŠå‰¯ä½œç”¨è­°é¡Œä¸Šå·² ä¸€ä¸€é€šéæª¢é©—ï¼Œä½† FDA å»èªç‚ºï¼Œé›–ç„¶ç´…éº´æ˜¯ä½¿ç”¨å¾ˆä¹…çš„é£Ÿç‰©ï¼Œä½†å› å…¶æ¨™æº–åŒ–å¾Œæ¯é£Ÿç”¨ 4.8 mg çš„**ç´…éº´æ¸…é†‡è† å›Š** ä¸­æœƒå«æœ‰ 5mg Lovastatinï¼Œæ˜¯ä»¥å…¶é™è„‚çš„ä½œç”¨å’Œæ©Ÿåˆ¶ï¼Œæ‡‰è¦–ç‚ºè—¥å“åˆ—ç®¡ã€‚

Pharmanex å‰‡åé§é“ï¼š

**ã€Œç´…éº´é›–ç„¶å«æœ‰ 5mg Lovastatinï¼Œä½†æ˜¯é€™å€‹æ˜¯ç´…éº´è£¡é¢è‡ªç„¶ç”¢ç”Ÿçš„éæ•…æ„æ·»åŠ ï¼Œè€Œä¸”ç¶“éé›™ç›²å¯¦é©—çµæœé¡¯ç¤ºé™è†½å›ºé†‡æ•ˆæœèˆ‡ä½¿ç”¨ 20mg Lovastatin ç›¸ç•¶ã€‚æˆ‘å¯æ²’æœ‰æ·»åŠ  20mg Lovastatin åœ¨æ­¤è£¡é¢ï¼æœ‰é€™æ¨£çš„æ•ˆæœä¸€å®šæ˜¯ç´…éº´ç”¢å“è£¡é¢å…¶ä»–ç‰©è³ªçš„ä½œç”¨ï¼**è«‹** æ³•å®˜å¤§äººæ˜å¯Ÿï¼ã€**

çµæœé€™å ´å°è¦ç±³å°å¤§é¯¨é­šçš„æˆ²ç¢¼ç«Ÿç„¶è´äº†

è¥¿å…ƒ 1999 å¹´ 2 æœˆï¼Œç¾åœ‹è¯é‚¦æ³•é™¢ç¬¬ä¸€æ¬¡åˆ¤æ±º Pharmanex ç²å‹ï¼Œæ–¼æ˜¯ä½¿ Pharmanex å’Œç”¢å“çŸ¥ååº¦å¤§é–‹ï¼›ç•¶æ™‚ä¸€é …é‡å°ç¾åœ‹æˆå¹´äººæ‰€åšçš„èª¿æŸ¥é¡¯ç¤ºï¼Œé«˜é” 60ï¼… å—è¨ªè€…éƒ½è½éã€Œ**ç´…éº´æ¸…é†‡è† å›Š** ã€ã€‚ 

Pharmanex è´äº†å‰é¢å…©æ¬¡å®˜å¸ï¼ŒFDA ä»ç¹¼çºŒä¸Šè¨´åˆ°ç¾åœ‹æœ€é«˜æ³•é™¢ï¼›è¥¿å…ƒ 2000 å¹´ 7 æœˆï¼Œæœ€é«˜æ³•é™¢æ¨ç¿»äº†åœ°æ–¹æ³•é™¢çš„è£æ±ºï¼Œç™¼å›æ›´å¯©ã€‚

æ³•å®˜é™¤äº†èªåŒ FDA çš„è—¥å“ä¸»å¼µå¤–ï¼ŒåŒæ™‚ä¹Ÿæ–¼åˆ¤æ±ºæ›¸ä¸­é—¡è¿°ï¼ŒåŸºæ–¼æ³•å¾‹æ•´é«”çš„è§£é‡‹ä¸¦è€ƒé‡æ–°è—¥ç ”ç™¼çš„èª˜å› ï¼Œã€Šè†³é£Ÿè£œå……å“å¥åº·èˆ‡æ•™è‚²æ³•æ¡ˆã€‹ï¼ˆThe Dietary Supplement Health and Education Actï¼ŒDSHEAï¼‰å®šç¾©ä¸­æ‰€è¿°ã€Œç‰©å“ï¼ˆArticleï¼‰ã€ï¼ŒåŒ…æ‹¬æœ€çµ‚æ ¸å‡†çš„è—¥å“åŠå…¶æœ‰æ•ˆæˆåˆ†ã€‚

æœ€å¾Œï¼ŒFDA è¦æ±‚ Pharmanex æ”¹è®Šé…æ–¹ï¼ŒPharmanex åœ¨ç¾åœ‹è²©å”®çš„ç´…éº´æ¸…é†‡è† å›Šä¸­æ–°é…æ–¹å«æœ‰ Policorï¼ˆå¤šäºŒåçƒ·é†‡ï¼‰ï¼Œé€™æ˜¯ä¸€ç¨®ã€Œä»¥**èœ‚è Ÿ** ç‚ºåŸºç¤ã€çš„å°ˆæœ‰æˆåˆ†ï¼Œå¯æŠ‘åˆ¶è‚è‡Ÿä¸­è†½å›ºé†‡çš„åˆæˆï¼›**ç¾åœ‹ä»¥å¤–åœ°å€å‰‡ä»å¯ç¶­æŒåŸé…æ–¹** ã€‚

## **å°æ—è£½è—¥ã€Œç´…éº´ã€äº‹ä»¶**

å¯«åœ¨å¾Œé ­ï¼Œæœ€è¿‘æ—¥æœ¬å°æ—è£½è—¥ã€Œç´…éº´ã€ä¿å¥é£Ÿå“é¢¨æš´æŒçºŒæ“´å¤§ï¼Œæ­»äº¡ç´¯è¨ˆ 5 äººã€ä½é™¢æ²»ç™‚ 114 äººï¼Œæ¶ˆè²»è€…ä¾†é›»è¶…é 1.5 è¬é€šã€‚æ—¥æœ¬å¤§é˜ªå¸‚æ”¿åºœå·²ç¶“å‹’ä»¤å°æ—å›æ”¶ 3 ç¨®ç´„ 100 è¬å€‹ç”¢å“ã€‚

åŒæ™‚æ—¥æœ¬ä¿å¥å…¬å¸ DHC éŠ·å”®åˆ°å°ç£çš„ã€Œæ¿ƒç¸®ç´…éº´ã€è† å›Šå’Œå°ç£æœ¬åœŸä¿å¥é£Ÿå“å» å¤§é†«ç”ŸæŠ€çš„ã€Œå¤§ç ”ç”Ÿé†«ç´è±†ç´…éº´ Q10 è† å›Šã€ï¼Œä¹Ÿå› ç‚ºé€™é …ç”¢å“æœ‰ä½¿ç”¨å°æ—è£½è—¥ç´…éº´åŸæ–™é›™é›™éƒ½å®£å‘Šå›æ”¶ç”¢å“ã€‚

æ—¥æœ¬åšç”Ÿå‹å‹•çœæœ€æ–°å…¬å¸ƒï¼Œå•é¡Œä¿å¥å“ä¸­ç™¼ç¾**è»Ÿæ¯›é’é»´é…¸** ï¼ˆPuberulic Acidï¼‰é€™ç¨®çš„æœªé æœŸç‰©è³ªï¼Œæ˜¯ç”±é’é»´èŒç”Ÿæˆçš„å¤©ç„¶åŒ–åˆç‰©ï¼Œæ¯’æ€§ç›¸ç•¶é«˜ã€‚

ææ‡¼æ˜¯æœƒè”“å»¶çš„

æ±äº¬éƒ½æ¶ˆè²»ç”Ÿæ´»ä¸­å¿ƒè«®è©¢èª²é•·é«˜æ‘æ·³å­ï¼šã€Œå°±ç®—ä¸æ˜¯ç´…éº´ï¼Œæ°‘çœ¾çœ‹åˆ°æœ‰ç´…å­—çš„æˆä»½ï¼Œæˆ–æ˜¯æ“æœ‰åŒæ¨£æ•ˆæœçš„ä»–ç‰Œç”¢å“ï¼Œéƒ½æœƒæ„Ÿåˆ°å®³æ€•ã€‚ã€

**å®‰å…¨** æ¯”**æœ‰æ•ˆ** æ›´é‡è¦

å›é ­çœ‹ï¼Œ6S å“ä¿çœŸçš„å¾ˆé‡è¦ï¼Œ**å®‰å…¨** çµ•å°æœƒæ¯”**æœ‰æ•ˆ** æ›´é‡è¦ã€‚æ¯ä¸€æ¬¡ç”¢å“çš„åŸæ–™æª¢é©—ã€æˆå“æª¢é©—éƒ½ä¸èƒ½å°‘ï¼Œé€™ä¸€é»å…¬å¸ç›®å‰åšçš„å¾ˆå¥½ï¼Œå¾ˆæ„Ÿæ©ã€‚

æˆ‘ä¸æœƒå› ç‚ºåˆ¥äººçš„ééŒ¯å°±è¦æ¶ˆè²»ä»–å€‘ï¼Œå¤§è‚†å®£æšæˆ‘å€‘å®¶çš„æœ€å¥½ï¼Œæ²’æœ‰è²·æˆ‘å€‘å®¶çš„å°±å®¹æ˜“ç™¼ç”Ÿäº‹æƒ…ï¼›åä¹‹æˆ‘æ˜¯æ„Ÿåˆ°é›£éï¼ŒåŒæ™‚ä¹Ÿæˆ’æ…ææ‡¼ï¼Œç•¢ç«Ÿæ¶ˆè²»è€…ä¿¡ä»»ä½ æ‰è²·ï¼Œä»»ä½•å¤±èª¤éƒ½ä¸èƒ½ç™¼ç”Ÿï¼Œå› ç‚ºå¯¶è²´ç”Ÿå‘½çš„æµé€éƒ½æœ‰å¯èƒ½ç™¼ç”Ÿåœ¨æ¯ä¸€æ¬¡çš„ç–å¿½ä¸Šã€‚

å»¶ä¼¸é–±è®€ï¼š

> [Nu Skin ç”¨ 6S çš„æ‰¿è«¾ä¾†å®ˆè­·ä½ çš„å¥åº·](https://agelocked.com/nu-skin-%e7%94%a8-6s-%e7%9a%84%e6%89%bf%e8%ab%be%e4%be%86%e5%ae%88%e8%ad%b7%e4%bd%a0%e7%9a%84%e5%81%a5%e5%ba%b7/)

> [ç‚ºä»€éº¼ Nu Skin æ•¢èªªä»–å€‘ä»¥è£½è—¥çš„æ¨™æº–ä¾†é–‹ç™¼ç‡Ÿé¤Šè£œå……å“ï¼Ÿ](https://agelocked.com/%e7%82%ba%e4%bb%80%e9%ba%bc-nu-skin-%e6%95%a2%e8%aa%aa%e4%bb%96%e5%80%91%e4%bb%a5%e8%a3%bd%e8%97%a5%e7%9a%84%e6%a8%99%e6%ba%96%e4%be%86%e9%96%8b%e7%99%bc%e7%87%9f%e9%a4%8a%e8%a3%9c%e5%85%85%e5%93%81/)

åƒè€ƒè³‡æ–™ï¼š  
01.MedSchool/[ç´…éº´æ˜¯ä»€éº¼ï¼Ÿå°ˆå®¶èªªæ˜ç´…éº´åŠŸæ•ˆèˆ‡å‰¯ä½œç”¨(æœ€å¾Œä¸€é …å¾ˆé‡è¦!)](https://medschool.cc/article/red-yeast-rice)  
02.é£ŸåŠ›/æ½˜å­æ˜/[ä¿å¥é£Ÿå“ç•¶ç´…ç‚¸å­é›ã€Œç´…éº´ã€ä¸­çš„æ©˜é»´ç´ ï¼Œåˆ°åº•å®‰ä¸å®‰å…¨ï¼Ÿ](https://www.foodnext.net/science/additives/preservative/paper/5357129591)  
03.éŸ‹æ©çš„åè¾²ç”Ÿæ´»/éŸ‹æ©/[ç´…éº´çš„åŠŸæ•ˆèˆ‡ç¦å¿Œ? ç´…éº´èƒ½é™è¡€è„‚ã€æŠ—ä¸‰é«˜ã€é é˜²è…¦è€åŒ–å— ?](https://tw.news.yahoo.com/%E4%BF%9D%E5%81%A5%E9%A3%9F%E5%93%81%E5%88%86%E6%9E%90-2021%E6%9C%80%E6%96%B0-%E7%B4%85%E9%BA%B4%E7%9A%84monacolin-k%E8%88%87ankascin-568-082317823.html)  
04.ç§‘å­¸ç™¼å±•441æœŸ/æ½˜å­æ˜/[å‰µé€ å¤å¯¶çš„æ–°åƒ¹å€¼â€”â€”ç´…éº´](https://ejournal.stpi.narl.org.tw/sd/download?source=9809/9809-03.pdf&vlId=9ED1A3C3-D349-4C92-B160-94210B1A9E55&nd=0&ds=0)  
05.è‡¨åºŠç”Ÿè—¥å­¸ç¬¬25å·ç¬¬4æœŸ/é™³æ€¡å­œã€æˆ´ä¿Šå…¸ã€æ—è‚² ã€é„­å¥•å¸ã€è¬å³æ–‡/[ç”±ç¾ä»£è—¥ç†èˆ‡å‚³çµ±åŠŸæ•ˆçœ‹ä¸­è—¥ç´…éº´](https://www.taiwan-pharma.org.tw/magazine/101/132-136.pdf)  
06.éƒ­å»ºå¿—/[æ·ºè«‡çœŸèŒä¹‹æ¯’ç´ ](https://www.tcdares.gov.tw/upload/tdais/files/web_structure/8187/TC0211631.pdf)  
07.é£ŸåŠ›/é»ƒéŒ¦åŸã€å»–å•Ÿæˆ/[é£Ÿç‰©ä¸­æ¯’æœ€å¸¸è¦‹çš„å…‡æ‰‹ï¼šå¾®ç”Ÿç‰©æ±™æŸ“](https://www.foodnext.net/life/lifesafe/paper/4739537459)  
08.ILSIç¤¾åœ˜æ³•äººå°ç£åœ‹éš›ç”Ÿå‘½ç§‘å­¸æœƒ/é™³æ¨¹åŠŸ/[2023å¹´ç¬¬3æœŸ-ç¾åœ‹è†³é£Ÿè£œå……å“çœŸé›£ç®¡](https://www.ilsitaiwan.org/Page/LTDetail?v=wngiRJFQb1n0g9vxOOrYJw%3D%3D&LTID=qjrHsf9Exg9m9JqtjhbnSw%3D%3D&NID=LiYwHsTWYwIS764Ats9O2g%3D%3D)  
09.ä¸­æ™‚æ–°èç¶²/æ —ç­±é›¯/[è£½è—¥ç´…éº´å·²é‡€5æ­» ç”¢å“æå«åŠ‡æ¯’ã€Œè»Ÿæ¯›é’é»´é…¸ã€](https://www.chinatimes.com/realtimenews/20240329004419-260408?chdtv)  
10\. Musaalbakri Abdul Manan, Rosfarizan Mohamad, Arbakariya Ariff, 2017.__[Monascus spp.: A source of Natural Microbial Color through Fungal Biofermentation.](https://medcraveonline.com/JMEN/monascus-spp-a-source-of-natural-microbial-color-through-fungal-biofermentation.html) _J Microbiol Exp._ 5(3): 00148.  
11\. Vishu Chaudhary, Priya Katyal, Anuj Kumar Poonia, Jaspreet Kaur, Anil Kumar Puniya, Harsh Panwar, 2022. [Natural pigment from Monascus: The production and therapeutic significance.](https://pubmed.ncbi.nlm.nih.gov/34569683/) _J Appl Microbiol._ 133(1):18-38.  
12\. H C Wong, Y S Bau, 1977. [Pigmentation and Antibacterial Activity of Fast Neutron- and X-Ray-induced Strains of Monascus purpureus Went.](https://pubmed.ncbi.nlm.nih.gov/16660141/) _Plant Physiol._ 60(4):578-81.  
13\. P J Blanc, J P Laussac, J Le Bars, P Le Bars, M O Loret, A Pareilleux, D Prome, J C Prome, A L Santerre, G Goma, 1995. [Characterization of monascidin A from Monascus as citrinin.](https://pubmed.ncbi.nlm.nih.gov/8579990/) _Int J Food Microbiol._ 27(2-3):201-13.  
14\. Arrigo F G Cicero, Federica Fogacci, Maciej Banach, 2019. [Red Yeast Rice for Hypercholesterolemia.](https://pubmed.ncbi.nlm.nih.gov/31687098/) _Methodist Debakey Cardiovasc J._ 15(3):192-199.  
15\. Pengfan Li, Qi Wang, Kanjun Chen, Shihui Zou, Shi Shu, Chanchan Lu, Shiyun Wang, Yunqin Jiang, Chunxiang Fan, Yue Luo, 2022. [Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High-Quality Randomized Controlled Trials.](https://pubmed.ncbi.nlm.nih.gov/35111069/) _Front Pharmacol._ 12:819482.  
16\. A Endo, 1979. [Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.](https://pubmed.ncbi.nlm.nih.gov/500505/) _J Antibiot (Tokyo)._ 32(8):852-4.  
17\. A W Alberts, J Chen, G Kuron, V Hunt, J Huff, C Hoffman, J Rothrock, M Lopez, H Joshua, E Harris, A Patchett, R Monaghan, S Currie, E Stapley, G Albers-Schonberg, O Hensens, J Hirshfield, K Hoogsteen, J Liesch, J Springer, 1980. [Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.](https://pubmed.ncbi.nlm.nih.gov/6933445/) _Proc Natl Acad Sci USA._ 77(7):3957-61.  
18\. J L Goldstein, M S Brown, 1984. [Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol.](https://pubmed.ncbi.nlm.nih.gov/6397553/) _Lipid Res._ 25(13):1450-61.  
19\. A Endo, K Hasumi, T Nakamura, M Kunishima, M Masuda, 1985. [Dihydromonacolin L and monacolin X, new metabolites which inhibit cholesterol biosynthesis.](https://pubmed.ncbi.nlm.nih.gov/3839224/) _J Antibiot (Tokyo)._ 32(8):852-4.  
20\. A Endo, K Hasumi, S Negishi, 1985. [Monascolins J and L, new inhibitors of cholesterol bioynthesis produced by Monascus ruber.](https://pubmed.ncbi.nlm.nih.gov/3839227/) _J Antibiot (Tokyo)._ 38(3):420-2.  
21\. A Endo, D Komagata, H Shimada, 1986. [Monacolin M, a new inhibitor of cholesterol biosynthesis.](https://pubmed.ncbi.nlm.nih.gov/3818440/) _J Antibiot (Tokyo)._ 39(12):1670-3.  
22\. K Tsuji, T Ichikawa, M Kawamura, Y Nakagawa, Abstracts of Papers, The Annual Meeting of the Agricultural Chemical Society of Japan, Kyoto, April 1986, p. 216.  
23\. Y Kohama, S Matsumoto, T Mimura, N Tanabe, A Inada, T Nakanishi, 1987. [Isolation and Identification of Hypotensive Principles in Red-Moldrice.](https://pubmed.ncbi.nlm.nih.gov/3664845/) _Chem Pharm Bull (Tokyo)._ 35(6):2484-9.  
24\. [éº¹ãŒé«˜è¡€åœ§è‡ªç„¶ç™ºç—‡ãƒ©ãƒƒãƒˆã®è¡€åœ§ã«åŠã¼ã™å½±éŸ¿](https://cir.nii.ac.jp/crid/1390282679482530944) è¾» å•“ä»‹, å¸‚å· å¯Œå¤«, ç”°è¾º ä¼¸å’Œ, é˜¿éƒ¨ å£«éƒ, æ¨½äº• åº„ä¸€, ä¸­å· é–æ æ—¥æœ¬è¾²èŠ¸åŒ–å­¦ä¼šèªŒ 66 (8), 1241-1246, 1992  
K Tsuji, T Ichikawa, N Tanabe, S Abe, S Tarui, Y Nakagawa, 1992. Effects of Two Kinds of Koji on Blood Pressure in Spontaneously Hypertensive Rats. _J. Agric. Chem. Soc. Japan_ , 66:1241-1246.  
25\. [ç´…éº¹æŠ½å‡ºç‰©ãŒæœ¬æ…‹æ€§é«˜è¡€åœ§è€…ã®è¡€åœ§ã«åŠã¼ã™å½±éŸ¿](https://cir.nii.ac.jp/crid/1390282681524967424) äº•ä¸Š æ¸…,å‘å±± ç¾é›„,è¾» å•“ä»‹,ç”°è¾º ä¼¸å’Œ,æ¨½äº• åº„ä¸€,é˜¿éƒ¨ å£«æœ—,é«˜æ©‹ èª  æ „é¤Šå­¦é›‘èªŒ 53 (4), 263-271, 1995  
T Kushiro, J Hashida, H Kawamura, H Mitsubayashi, T Saito, Y Suzuki, N Takahashi, T Ishii, T Kimura, K Tsuji, N Tanabe, K Asano, S Abe, S Tarui, 1996. [Clinical effects of beni-koji in mild essential hypertensionâ€“a multi-center double-blind comparison with placebo.](https://pubmed.ncbi.nlm.nih.gov/9014483/) _Nihon Jinzo Gakkai Shi._ 38(12):625-33.  
26\. Maaike C Gerards, Ruben J Terlou, Huixin Yu, C H W Koks, V E A Gerdes, 2015. [Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain â€“ a systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/25897793/)  _Atherosclerosis._ 2015;240(2):415â€“23.  
27\. Arrigo F G Cicero, Federica Fogacci, Anca Pantea Stoian, Peter P Toth, 2023. [Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review.](https://pubmed.ncbi.nlm.nih.gov/37242171/) _Nutrients._ 15(10):2288.  
28\. Jelani K Grant, Michael Dangl, Chiadi E Ndumele, Erin D Michos, Seth S Martin, 2024. A [historical, evidence-based, and narrative review on commonly used dietary supplements in lipid-lowering.](https://pubmed.ncbi.nlm.nih.gov/38145747/) _J Lipid Res._ 2024 65(2):100493.  
29\. Abdul Halim Farawahida, Jon Palmer, Steve Flint, 2022. [Monascus spp. and citrinin: Identification, selection of Monascus spp. isolates, occurrence, detection and reduction of citrinin during the fermentation of red fermented rice.](https://pubmed.ncbi.nlm.nih.gov/35863149/) I _nt J Food Microbiol._ 379:109829.  
30\. Wei Wei, Changling Li, Yinye Wang, Huaide Su, Jiashi Zhu, David Kritchevsky, 2003. [Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits.](https://pubmed.ncbi.nlm.nih.gov/12873712/) _J Nutr Biochem._ 14(6):314-8.  
31\. J Ma, Y Li, Q Ye, J Li, Y Hua, D Ju, D Zhang, R Cooper, M Chang, 2000. [Constituents of red yeast rice, a traditional Chinese food and medicine.](https://pubmed.ncbi.nlm.nih.gov/11087463/) _J Agric Food Chem._ 48(11):5220-5.  
32\. D Heber, I Yip, J M Ashley, D A Elashoff, R M Elashoff, V L Go, 1999. [Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.](https://pubmed.ncbi.nlm.nih.gov/9989685/) _Am J Clin Nutr._ 69(2):231-6.  
33\. Liang Zhang, Zhiqiang Li, Bing Dai, Wenxue Zhang, Yongjun Yuan, 2013. [Effect of submerged and solid-state fermentation on pigment and citrinin production by Monascus purpureus.](https://pubmed.ncbi.nlm.nih.gov/24013899/) _Acta Biol Hung._ 64(3):385-94.  
34\. Ricky Y K Man, Edward G Lynn, Filly Cheung, Patricia S Y Tsang, Karmin O, 2002. [Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2).](https://pubmed.ncbi.nlm.nih.gov/12083370/) _Mol Cell Biochem._ 233(1-2):153-8.   
35\. Chih-Pei Lin, Yung-Hsiang Chen, Jaw-Wen Chen, Hsin-Bang Leu, Tsan-Zon Liu, Po-Len Liu, Song-Lih Huang, 2008. [Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappaB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells.](https://pubmed.ncbi.nlm.nih.gov/17906965/) _J Biomed Sci._  
15(2):183-96.  
36\. D Heber, A Lembertas, Q Y Lu, S Bowerman, V L Go, 2001.[ An Analysis of Nine Proprietary Chinese Red Yeast Rice Dietary Supplements: Implications of Variability in Chemical Profile and Contents.](https://pubmed.ncbi.nlm.nih.gov/11327519/) _J Altern Complement Med._ 7(2):133-9.  
37\. YEN-HUNG YEH, YA-TING LEE, HUNG-SHENG HSIEH AND DENG-FWU HWANG, 2010. [Dietary Cholestin (Red Yeast Extract) Reduces Toxicity of Oxidized Cholesterol in Rats.](https://www.jfda-online.com/journal/vol18/iss3/6/) _J FOOD DRUG ANA._ 18(3):211-220  
38\. Bharathi Avula, Pieter A Cohen, Yan-Hong Wang, Satyanarayanaraju Sagi, Wei Feng, Mei Wang, Jerry Zweigenbaum, Ma Shuangcheng, Ikhlas A Khan, 2014.[ Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF mass spectrometry: Chemometrics application.](https://pubmed.ncbi.nlm.nih.gov/25168220/) _J Pharm Biomed Anal._ 100:243-253.[  
](https://www.tcdares.gov.tw/upload/tdais/files/web_structure/8187/TC0211631.pdf)39\. Abdul Halim Farawahida, Jon Palmer, Steve Flint, 2022. [_Monascus_ spp. and citrinin: Identification, selection of  _Monascus_ spp. isolates, occurrence, detection and reduction of citrinin during the fermentation of red fermented rice.](https://pubmed.ncbi.nlm.nih.gov/35863149/) _Int J Food Microbiol._ 379:109829.  
40.Nutraceuticals World/Todd Harrison/[Capitol Comments: The Cholestin Case: The Ongoing Saga](https://www.nutraceuticalsworld.com/issues/2001-06/view_columns/capitol-comments-the-cholestin-case-the-ongoing-sa/)  
41.R J Havel,1999. [Dietary supplement or drug? The case of cholestin.](https://pubmed.ncbi.nlm.nih.gov/9989677/) _Am J Clin Nutr._ 69(2):175-6.  
42.Alan Dumoff/[It Merck or Is It Pharmanex? The Regulatory Tale of Lovastatin and Cholestin](https://www.liebertpub.com/doi/abs/10.1089/107628001753312167?journalCode=act)

å–œæ­¡æˆ‘å¯«çš„å…§å®¹å—?  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€å‘Šè¨´æˆ‘ä½ çš„æ„Ÿæƒ³èˆ‡è©•è«– ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)

æƒ³ç¬¬ä¸€æ‰‹æ¥æ”¶ç”¢å“å¿«è¨Šèˆ‡ç§‘å­¸æ–°çŸ¥å—ï¼Ÿ  
æœ‰æ­é…å¦‚æ–°ä¿å¥å“å•é¡Œæƒ³å•å—ï¼Ÿ  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€åšè«®è©¢ ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)